Results for tag: "Retinopathy Of Prematurity Drug"

Retinopathy of Prematurity (ROP) is a disorder of the eye that affects premature infants. It is caused by abnormal growth of the blood vessels in the retina, which can lead to vision loss. Treatment for ROP includes laser therapy, cryotherapy, and intravitreal injections. Optical Disorders Drugs are used to treat ROP and other eye diseases. These drugs are designed to reduce inflammation, improve vision, and prevent further damage to the retina. They can also be used to treat other eye conditions such as glaucoma and macular degeneration. The Retinopathy of Prematurity Drug market is a rapidly growing sector of the Optical Disorders Drugs market. Companies in this market are focused on developing new treatments and therapies for ROP and other eye diseases. Some of the major players in this market include Allergan, Novartis, Regeneron, and Roche. Other companies such as Bausch + Lomb, Santen, and Ophthotech are also active in this market. Show Less Read more